| 1 |
33426680 | Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2. | 2021 Mar |
2 |
| 2 |
31778273 | Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. | 2020 Feb |
4 |
| 3 |
27245475 | Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer. | 2016 Nov |
1 |
| 4 |
23232555 | Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents. | 2013 Feb |
1 |
| 5 |
23271323 | Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy. | 2013 Mar |
3 |
| 6 |
23846927 | Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications. | 2013 Jul 10 |
1 |
| 7 |
24280569 | Human equilibrative nucleoside transporter 1 (hENT1): do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients? | 2013 Nov-Dec |
1 |
| 8 |
22091436 | Novel strategy with gemcitabine for advanced pancreatic cancer. | 2011 |
1 |
| 9 |
20824050 | Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. | 2010 Sep |
1 |
| 10 |
21443122 | Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer. | 2010 Nov-Dec |
4 |
| 11 |
18383843 | Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts. | 2008 Jan-Feb |
4 |
| 12 |
18490900 | Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma. | 2008 Jul |
1 |
| 13 |
17695509 | Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer. | 2007 Jul-Aug |
4 |
| 14 |
16868479 | Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model. | 2006 Aug |
4 |